Infectious Disease Control

Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring

AUSTIN, Texas, July 22, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working w...

2021-07-22 20:00 11338

Within weeks of first COVID-19 outbreak, China's Qingdao Weida Biotechnology had switched all production capability over to PPE

QINGDAO, China, July 19, 2021 /PRNewswire/ -- On July 16, 2021, organized by the Information Office of the People's Government of Shandong Province, a delegation of journalists from foreign media organizations who were participating in the 2021 Qingdao Multinationals Summit (QMS) paid a visit to ...

2021-07-20 07:15 1177

Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

SUZHOU, China, July 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced thatParaguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emerg...

2021-07-16 14:41 36267

Kintor Pharmaceutical Collaborates with Fosun Pharma Development to Commercialise Proxalutamide for Treatment of COVID-19 in India and Africa

SUZHOU, China, July 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. ("Fosun Pharma Development"), on the commercialisation of proxalutamide for the treatment of CO...

2021-07-15 10:00 33775

Pandemic fight, economy among China topics of interest in survey

BEIJING, July 2, 2021 /PRNewswire/ -- A report from chinadaily.com.cn: An online survey which began in February by China Daily and its global media outlets found thatChina's anti-pandemic experience and economic development were the top topics global netizens are most interested in.

2021-07-02 21:50 2627

Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology

SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.

2021-07-01 21:00 1640

Vazyme Brings COVID-19 Testing Solutions at Medlab 2021

DUBAI, UAE, June 25, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) showcased its lineup of COVID-19 testing solutions and its point-of-care testing (POCT) in vitro diagnostic instruments at the 2021 Medlab Middle East, an industry-leading medical labo...

2021-06-25 15:31 1330

Senhwa Announces IND Submission to India's CDSCO of a Phase II Clinical Study for Silmitasertib as a Potential COVID-19 Treatment

TAIPEI and SAN DIEGO, June 23, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on developing first-in-class therapeutics for the treatment of cancer, rare conditions, and novel coronaviruses, today announced that it has submitted an I...

2021-06-23 19:00 1246

Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test

PISCATAWAY, N.J. and SINGAPORE, June 21, 2021  /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, annou...

2021-06-21 19:27 7924

iXensor Launches CE-marked Fully Digitized PixoTest COVID-19 Rapid Test with Digital Health Pass to Facilitate Safe Reopening of Economies

* A computer vision empowered rapid antigen test to avoid human errors. * An end-to-end digitized screening solution delivers test-to-report time in around 15 minutes. * The enterprise SaaS solution enables organizations to reopen with confidence. TAIPEI, June 3, 2021 /PRNewswire/ -- iXens...

2021-06-03 17:00 1948

Shanghai Asclepius Meditec and International Department of Central Committee of CPC Collaborate to Provide Emergency Support to Fight COVID-19 in Nepal

SHANGHAI, June 2, 2021 /PRNewswire/ -- The President of Asclepius Meditec – the company behind the innovativeHydrogen Oxygen Generator with Nebulizer

2021-06-02 20:00 1389

TCI Co., Ltd. named as one of Asia's fastest growing companies by The Financial Times

TAIPEI, May 25, 2021 /PRNewswire/ -- TCI Co., Ltd. (8436. TWO), a leading nutraceutical ODM company, has earned a position in the exclusive ranking of High-Growth Companies inAsia-Pacific 2021. TCI, has been ranked top 15 among Taiwanese companies, registering an absolute growth rate of 207.6% an...

2021-05-26 11:07 2061

Aussie LegalTech Startup Goes Global With COVID-19 Diagnosis Tool

* Australian LegalTech startup, Rulestar, is taking its automation platform global and expanding beyond the legal industry. * Rulestar has released an automated COVID-19 diagnosis tool as a new proof-of-concept product. * This demonstrates how automation technologies can improve decision-mak...

2021-05-25 22:25 1444

A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal

SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the 24th that CNPharm, its major shareholding bio tech company, published an article containing the research results of CP-COV03, a Niclosamide-based oral treatment for COVID-19 based on its proprietar...

2021-05-24 08:16 1519

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing a fully integrated end-to-end contract develop...

2021-05-23 00:00 8663

Island Pharmaceuticals granted key patent for ISLA-101 in the United States

* Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office * Patent underpins Island's drug repurposing strategy to rapidly and efficiently develop antiviral therapies with a key focus being mosquito borne viral diseases, such as dengue fever. * Around 3...

2021-05-19 19:30 1390

GenScript Launches Research-Grade Lentiviral Vector Packaging Service

PISCATAWAY, N.J., April 28, 2021 /PRNewswire/ -- GenScript® , the world's leading reagents provider, announced today the launch of its Research Lentiviral Vector Packaging Service for cell lin...

2021-04-28 19:30 2195

Vaccines: More cooperation, less speculation

BEIJING, April 22, 2021 /PRNewswire/ -- A news report by China.org.cn on China's attitude towards China-US trade friction: Recently, there have been media reports saying that a Chinese official "admitted" low effectiveness of the country's COVID-19 vaccines. Given that many countries have alread...

2021-04-22 21:00 1564

CNPharm has succeeded in maintaining IC100 for 24 hours with one injection

- Trail-blazing diversification of the repurposing of Niclosamide - Full-scale clinical preparation of injections for severely ill patients SEOUL, South Korea, April 19, 2021 /PRNewswire/ -- Hyundai Bioscience (Symbol 048410), a KOSDAQ listed company, announced on the 19th that its major sharehol...

2021-04-19 20:15 1388

China Eastern Flies Vaccines to Dominican Republic

SHANGHAI, March 25, 2021 /PRNewswire/ -- A new batch of vaccines developed by Chinese pharmaceutical companies Sinopharm and Sinovac was delivered onMarch 18 by China Eastern Airlines fromBeijing to the Dominican Republic, according to theShanghai-based airline.

2021-03-25 19:22 1506
1 ... 3456789 ... 13